FANCG |
O15287
|
FA complementation group G
|
|
2.5E-14 |
0.556 |
0.769 |
FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
RAD51C |
O43502
|
RAD51 paralog C
|
|
6.2E-14 |
0.533 |
0.692 |
XRCC2 |
O43543
|
X-ray repair cross complementing 2
|
|
4.0E-07 |
0.512 |
0.731 |
TGFB1 |
P01137
|
transforming growth factor beta 1
|
Signaling
|
3.7E-02 |
0.287 |
0.962 |
APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
MMP2 |
P08253
|
matrix metallopeptidase 2
|
Enzyme
|
0.84 |
0.333 |
0.923 |
CBS |
P0DN79 P35520
|
cystathionine beta-synthase
|
Enzyme
|
3.1E-05 |
0.465 |
0.885 |
SLC2A1 |
P11166
|
solute carrier family 2 member 1
|
Transporter
|
0.99 |
0.388 |
0.808 |
BDNF |
P23560
|
brain derived neurotrophic factor
|
Signaling
|
0.66 |
0.345 |
0.923 |
NOS3 |
P29474
|
nitric oxide synthase 3
|
|
6.7E-07 |
0.378 |
0.885 |
BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
PCYT1A |
P49585
|
phosphate cytidylyltransferase 1, choline, alpha
|
|
2.0E-05 |
0.485 |
0.885 |
BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
FANCC |
Q00597
|
FA complementation group C
|
|
2.8E-13 |
0.507 |
0.808 |
RAD51 |
Q06609
|
RAD51 recombinase
|
|
2.7E-02 |
0.447 |
0.846 |
RFWD3 |
Q6PCD5
|
ring finger and WD repeat domain 3
|
Enzyme
|
3.5E-10 |
0.569 |
0.731 |
PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
SLX4 |
Q8IY92
|
SLX4 structure-specific endonuclease subunit
|
|
1.6E-22 |
0.565 |
0.731 |
FANCM |
Q8IYD8
|
FA complementation group M
|
Enzyme
|
2.4E-15 |
0.543 |
0.731 |
FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
ERCC4 |
Q92889
|
ERCC excision repair 4, endonuclease catalytic subunit
|
Enzyme
|
1.4E-12 |
0.468 |
0.846 |
BRIP1 |
Q9BX63
|
BRCA1 interacting protein C-terminal helicase 1
|
Enzyme
|
6.2E-17 |
0.507 |
0.731 |
FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |